Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Viemed Healthcare (VMD) Amortization of Deferred Charges (2024 - 2025)

Viemed Healthcare (VMD) has disclosed Amortization of Deferred Charges for 2 consecutive years, with $107000.0 as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Amortization of Deferred Charges rose 105.77% year-over-year to $107000.0, compared with a TTM value of $228000.0 through Dec 2025, up 21.93%, and an annual FY2025 reading of $228000.0, up 21.93% over the prior year.
  • Amortization of Deferred Charges was $107000.0 for Q4 2025 at Viemed Healthcare, up from $57000.0 in the prior quarter.
  • Across five years, Amortization of Deferred Charges topped out at $107000.0 in Q4 2025 and bottomed at $29000.0 in Q2 2025.